azelnidipine has been researched along with Anterior Choroidal Artery Infarction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Al-Mudhafar, A; Fakharaldeen, Z; Hadi, N; Radhi, A | 1 |
Hirano, T; Okamoto, S; Shiraishi, S; Tomiguchi, S; Uchino, M; Watanabe, M | 1 |
1 trial(s) available for azelnidipine and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study.
Topics: Aged; Azetidinecarboxylic Acid; Blood Pressure; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Cerebrovascular Circulation; Dihydropyridines; Female; Follow-Up Studies; Functional Laterality; Heart Rate; Humans; Hypertension; Image Processing, Computer-Assisted; Iofetamine; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Stroke; Tomography, Emission-Computed, Single-Photon | 2010 |
1 other study(ies) available for azelnidipine and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
Potential protective effects of Azelnidipine against cerebral ischemia-reperfusion injury in male rats.
Topics: Animals; Antioxidants; Brain Ischemia; Cerebral Infarction; Intercellular Adhesion Molecule-1; Interleukin-10; Interleukin-6; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2022 |